456 related articles for article (PubMed ID: 32791985)
1. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
2. Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.
Iacovelli NA; Naimo S; Bonfantini F; Cavallo A; Bossi P; Fallai C; Pignoli E; Alfieri S; Bergamini C; Favales F; Orlandi E
Support Care Cancer; 2017 Jun; 25(6):1787-1795. PubMed ID: 28108819
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
Chou HL; Shueng PW; Liao LJ; Hsu CX; Kuo DY; Lo WC; Hou PY; Wang LY; Chou SF; Hsieh CH
Radiat Oncol; 2019 May; 14(1):90. PubMed ID: 31146741
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
5. Bacterial Decolonization for Prevention of Radiation Dermatitis: A Randomized Clinical Trial.
Kost Y; Deutsch A; Mieczkowska K; Nazarian R; Muskat A; Hosgood HD; Lin J; Daily JP; Ohri N; Kabarriti R; Shinoda K; McLellan BN
JAMA Oncol; 2023 Jul; 9(7):940-945. PubMed ID: 37140904
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
[TBL] [Abstract][Full Text] [Related]
7. Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 May; 158():268-275. PubMed ID: 33711412
[TBL] [Abstract][Full Text] [Related]
8. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
9. A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial.
Robijns J; Van Bever L; Hermans S; Claes M; Lodewijckx J; Lenaerts M; Tuts L; Vandaele E; Vinken E; Noé L; Verboven K; Maes A; Van de Velde AS; Bulens P; Bulens P; Van den Bergh L; Mebis J
Support Care Cancer; 2023 Oct; 31(12):625. PubMed ID: 37819539
[TBL] [Abstract][Full Text] [Related]
10. Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas.
Liao Y; Feng G; Dai T; Long F; Tang J; Pu Y; Zheng X; Cao S; Xu S; Du X
Medicine (Baltimore); 2019 Dec; 98(52):e18230. PubMed ID: 31876704
[TBL] [Abstract][Full Text] [Related]
11. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
12. Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients.
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Lodewijckx J; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Support Care Cancer; 2019 Apr; 27(4):1245-1254. PubMed ID: 30270415
[TBL] [Abstract][Full Text] [Related]
13. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
14. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.
Rades D; Narvaez CA; Doemer C; Janssen S; Olbrich D; Tvilsted S; Conde-Moreno AJ; Cacicedo J
Trials; 2020 May; 21(1):424. PubMed ID: 32450921
[TBL] [Abstract][Full Text] [Related]
16. Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients.
Winkfield KM; Hughes RT; Brown DR; Clohessy RM; Holder RC; Russell GB; Rejeski AF; Burnett LR
Technol Cancer Res Treat; 2024; 23():15330338231222137. PubMed ID: 38186361
[No Abstract] [Full Text] [Related]
17. Topical betamethasone for prevention of radiation dermatitis.
Omidvari S; Saboori H; Mohammadianpanah M; Mosalaei A; Ahmadloo N; Mosleh-Shirazi MA; Jowkar F; Namaz S
Indian J Dermatol Venereol Leprol; 2007; 73(3):209. PubMed ID: 17561562
[TBL] [Abstract][Full Text] [Related]
18. Radiation-Induced Skin Dermatitis: Treatment With CamWell® Herb to Soothe® Cream in Patients With Head and Neck Cancer Receiving Radiation Therapy.
Pozoulakis EC; Cheng Z; Han P; Quon H
Clin J Oncol Nurs; 2021 Aug; 25(4):E44-E49. PubMed ID: 34269339
[TBL] [Abstract][Full Text] [Related]
19. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial.
Bazire L; Fromantin I; Diallo A; de la Lande B; Pernin V; Dendale R; Fourquet A; Savignoni A; Kirova YM
Radiother Oncol; 2015 Nov; 117(2):229-33. PubMed ID: 26328937
[TBL] [Abstract][Full Text] [Related]
20. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]